Percutaneous Closure in Transfemoral Aortic Valve Implantation: A Single-Centre Experience

详细信息    查看全文

• 作者：Charlotte Ebeling Barbier ; Elin Lundin…
• 关键词：Arterial intervention ; Transcatheter therapy ; Aorta
• 刊名：CardioVascular and Interventional Radiology
• 出版年：2015
• 出版时间：December 2015
• 年：2015
• 卷：38
• 期：6
• 页码：1438-1443
• 全文大小：392 KB
• 参考文献：1.Gilard M, Eltchaninoff H, Iung B, et al. Registry of transcatheter aortic-valve implantation in high-risk patients. N Engl J Med. 2012;366(18):1705鈥?5.CrossRef PubMed
  2.Leon MB, Smith CR, Mack M, et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med. 2010;363(17):1597鈥?07.CrossRef PubMed
  3.Hayashida K, Lefevre T, Chevalier B, et al. Transfemoral aortic valve implantation new criteria to predict vascular complications. JACC Cardiovasc Interv. 2011;4(8):851鈥?.CrossRef PubMed
  4.Etezadi V, Katzen BT, Naiem A, et al. Percutaneous suture-mediated closure versus surgical arteriotomy in endovascular aortic aneurysm repair. J Vasc Interv Radiol. 2011;22(2):142鈥?.CrossRef PubMed
  5.Van Mieghem NM, Tchetche D, Chieffo A, et al. Incidence, predictors, and implications of access site complications with transfemoral transcatheter aortic valve implantation. Am J Cardiol. 2012;110(9):1361鈥?.CrossRef PubMed
  6.Hayashida K, Lefevre T, Chevalier B, et al. True percutaneous approach for transfemoral aortic valve implantation using the Prostar XL device: impact of learning curve on vascular complications. JACC Cardiovasc Interv. 2012;5(2):207鈥?4.CrossRef PubMed
  7.Genereux P, Webb JG, Svensson LG, et al. Vascular complications after transcatheter aortic valve replacement: insights from the PARTNER (Placement of AoRTic TraNscathetER Valve) trial. J Am Coll Cardiol. 2012;60(12):1043鈥?2.CrossRef PubMed
  8.Toggweiler S, Gurvitch R, Leipsic J, et al. Percutaneous aortic valve replacement: vascular outcomes with a fully percutaneous procedure. J Am Coll Cardiol. 2012;59(2):113鈥?.CrossRef PubMed
  9.Vavuranakis M, Kariori M, Voudris V, et al. Predictive factors of vascular complications after transcatheter aortic valve implantation in patients treated with a default percutaneous strategy. Cardiovasc Ther. 2013;31(5):e46鈥?4.CrossRef PubMed
  10.Jernberg T, Attebring MF, Hambraeus K, et al. The Swedish Web-system for enhancement and development of evidence-based care in heart disease evaluated according to recommended therapies (SWEDEHEART). Heart. 2010;96(20):1617鈥?1.CrossRef PubMed
  11.Diethrich EB. What do we need to know to achieve durable endoluminal abdominal aortic aneurysm repair? Tex Heart Inst J. 1997;24(3):179鈥?4.PubMedCentral PubMed
  12.Larzon T, Geijer H, Gruber G, Popek R, Norgren L. Fascia suturing of large access sites after endovascular treatment of aortic aneurysms and dissections. J Endovasc Ther. 2006;13(2):152鈥?.CrossRef PubMed
  13.Kappetein AP, Head SJ, Genereux P, et al. Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. J Am Coll Cardiol. 2012;60(15):1438鈥?4.CrossRef PubMed
  14.Mehran R, Rao SV, Bhatt DL, et al. Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium. Circulation. 2011;123(23):2736鈥?7.CrossRef PubMed
  15.Cockburn J, de Belder A, Brooks M, et al. Large calibre arterial access device closure for percutaneous aortic valve interventions: use of the Prostar system in 118 cases. Catheter Cardiovasc Interv. 2012;79(1):143鈥?.CrossRef PubMed
  16.Czerwinska-Jelonkiewicz K, Michalowska I, Witkowski A, et al. Vascular complications after transcatheter aortic valve implantation (TAVI): risk and long-term results. J Thromb Thrombolysis. 2014;37(4):490鈥?.PubMedCentral CrossRef PubMed
  17.Thomas C, Steger V, Heller S, et al. Safety and efficacy of the Prostar XL vascular closing device for percutaneous closure of large arterial access sites. Radiol Res Pract. 2013;2013:875484.PubMedCentral PubMed
  18.Skagius E, Bosnjak M, Bjorck M, Steuer J, Nyman R, Wanhainen A. Percutaneous closure of large femoral artery access with Prostar XL in thoracic endovascular aortic repair. Eur J Vasc Endovasc Surg. 2013;46(5):558鈥?3.CrossRef PubMed
  19.Nelson PR, Kracjer Z, Kansal N, et al. A multicenter, randomized, controlled trial of totally percutaneous access versus open femoral exposure for endovascular aortic aneurysm repair (the PEVAR trial). J Vasc Surg. 2014;59(5):1181鈥?3.CrossRef PubMed
  20.Vergnat M, Finet G, Rioufol G, Obadia JF. Percutaneous femoral artery access with Prostar device for innovative mitral and aortic interventions. Eur J Cardiothorac Surg. 2011;39(4):600鈥?.CrossRef PubMed
  21.Hayashida K, Morice MC, Chevalier B, et al. Sex-related differences in clinical presentation and outcome of transcatheter aortic valve implantation for severe aortic stenosis. J Am Coll Cardiol. 2012;59(6):566鈥?1.CrossRef PubMed
  22.Harrison GJ, Thavarajan D, Brennan JA, Vallabhaneni SR, McWilliams RG, Fisher RK. Fascial closure following percutaneous endovascular aneurysm repair. Eur J Vasc Endovasc Surg. 2011;41(3):346鈥?.CrossRef PubMed
  
• 作者单位：Charlotte Ebeling Barbier (1)
  Elin Lundin (1)
  Vilyam Melki (2)
  Stefan James (3)
  Rickard Nyman (1)
  
  1. Department of Radiology, Uppsala University Hospital, Uppsala, Sweden
  2. Department of Thoracic Surgery, Uppsala University Hospital, Uppsala, Sweden
  3. Department of Cardiology, Uppsala University Hospital, Uppsala, Sweden
  
• 刊物类别：Medicine
• 刊物主题：Medicine & Public Health
  Imaging and Radiology
  Nuclear Medicine
  Ultrasound
  Cardiology
  
• 出版者：Springer New York
• ISSN：1432-086X

文摘

Purpose To report the experience of a percutaneous closure device used for transfemoral transcatheter aortic valve implantation (TAVI) in an unselected patient and operator population.